Abstract LB120: Driver-specific MRD strategy associated with pathological response and predicted recurrence in stage III driver-mutant NSCLC receiving neoadjuvant treatment
Year: 2026
Type: conference-abstract
Source: Cancer Research
Institutions: First Affiliated Hospital Zhejiang University, Zhejiang University, Shanghai Jiao Tong University, Shanghai Chest Hospital, Zhengzhou University, First Affiliated Hospital of Zhengzhou University, Zhejiang Cancer Hospital, University of Chinese Academy of Sciences, Xiamen Municipal Bureau of Science and Technology
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7154707033
Cites:
Cited by:
Related to: